Open- | Close- |
Vol / Avg.2.000 / 298.206K | Mkt Cap57.264M |
Day Range- - - | 52 Wk Range0.360 - 5.750 |
ADC Therapeutics Stock (NYSE: ADCT) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.000 / 298.206K | Mkt Cap57.264M |
Day Range- - - | 52 Wk Range0.360 - 5.750 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.630 | -0.410 | 0.2200 | ||||
REV | 15.990M | 14.493M | -1.497M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-20 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 12.00 | 3.00 |
2023-11-09 | TD Cowen | Boris Peaker | Downgrades | OutperformMarket Perform | - | - | - |
2023-11-08 | RBC Capital | Gregory Renza | Maintains | OutperformOutperform | Lowers | 7.00 | 6.00 |
2023-09-19 | HC Wainwright & Co. | Robert Burns | Reiterates | BuyBuy | Maintains | - | 12.00 |
You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.
There are no as such competitors for ADC Therapeutics.
The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by HC Wainwright & Co. on Monday, November 20, 2023. The analyst firm set a price target for 3.00 expecting ADCT to rise to within 12 months (a possible 322.48% upside). 15 analyst firms have reported ratings in the last year.
The stock price for ADC Therapeutics (NYSE: ADCT) is $0.7101 last updated November 24, 2023 at 12:57 PM UTC.
There is no dividend information for ADC Therapeutics.
ADC Therapeutics’s Q4 earnings are confirmed for Tuesday, February 27, 2024.
There is no upcoming split for ADC Therapeutics.
ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.